share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

辉瑞 | 4:持股变动声明-高管 JOHNSON RADY A
美股SEC公告 ·  11/02 03:27

Moomoo AI 已提取核心信息

Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), has executed a transaction involving the company's shares on October 31, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Johnson's investment in the company, but without further details, the impact on his total holdings remains unclear.
Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), has executed a transaction involving the company's shares on October 31, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Johnson's investment in the company, but without further details, the impact on his total holdings remains unclear.
辉瑞公司(PFE)执行副总裁Rady A Johnson于2024年10月31日执行了涉及公司股票的交易。交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值,在公告中并未披露。此举反映了Johnson对公司投资的变化,但缺乏进一步的细节,对其总持股的影响仍不明确。
辉瑞公司(PFE)执行副总裁Rady A Johnson于2024年10月31日执行了涉及公司股票的交易。交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值,在公告中并未披露。此举反映了Johnson对公司投资的变化,但缺乏进一步的细节,对其总持股的影响仍不明确。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息